425

Filed by Alpha Beta Netherlands Holding N.V.

Pursuant to Rule 425 under the Securities Act of 1933

Subject Companies:

NYSE Euronext

(Commission File No. 001-33392)

Deutsche Börse

November 3, 2011

 

 


Exhibit 99.1

LOGO

 

CONTACT | Media:   
+31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels)    CONTACT | Investor Relations:
+351.217.900.029 (Lisbon), +44.20.7379.2789 (London)    +1.212.656.5700 (New York)
+1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)    +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Third Quarter 2011 Financial Results

- Third Quarter GAAP Diluted EPS Up 56% Versus Prior Year to $0.76 -

- Diluted EPS Up 54% to $0.71 Excluding Merger Expenses, Exit Costs and Discrete Tax Benefit -

- Net Revenue Up 18% to $704 Million, Highest Level of Net Revenue Generation Since Third Quarter 2008 -

- Global Leader for IPOs Year-to-Date -

- $100 Million Stock Buy-Back Plan Previously Announced -

Financial and Operating Highlights1, 2

 

 

Diluted EPS of $0.71 vs. $0.46, up 54% vs. 3Q10

 

 

Net revenue of $704 million, up 18% vs. 3Q10, including $23 million positive FX impact

 

 

Fixed operating expenses of $416 million, down 5% on a constant dollar/portfolio basis vs. 3Q10

 

 

Operating income of $288 million, up 60% vs. 3Q10, including $13 million positive FX impact

 

 

Operating margin increases to 41% on continued strong cost discipline

 

 

Debt-to-EBITDA ratio declines to 1.6 times

 

 

Board declares third quarter 2011 cash dividend of $0.30 per share

 

1

All comparisons versus 3Q10 unless otherwise stated. Excludes merger expenses, exit costs and discrete tax items.

2 

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.

NEW YORK – November 3, 2011 – NYSE Euronext (NYX) today reported net income of $200 million, or $0.76 per diluted share, for the third quarter of 2011, compared to net income of $128 million, or $0.49 per diluted share, for the third quarter of 2010. Results for the third quarter of 2011 and 2010 include $29 million and $25 million, respectively, of pre-tax merger expenses and exit costs. The $29 million in merger expenses and exit costs in the third quarter of 2011 included $19 million related to the proposed merger with Deutsche Boerse AG. In the third quarter of 2011, our GAAP effective tax rate included a discrete deferred tax benefit of approximately $40 million related to the enacted reduction in the corporate tax rate from 27% to 25% in the United Kingdom. Excluding merger expenses, exit costs and discrete tax items, net income in the third quarter of 2011 was $186 million, or $0.71 per diluted share, compared to $121 million, or $0.46 per diluted share, in the third quarter of 2010.

“Our strong third quarter results benefited from unseasonably strong trading volumes, as well as our continuing business diversification efforts,” said Duncan L. Niederauer, CEO, NYSE Euronext. “Non-trading related net revenue was up $30 million year-over-year, driven by growth in our technology services businesses and the increasing momentum we are experiencing in our global listings franchise.

“We are moving forward with our merger with Deutsche Boerse and have just recently conducted a hearing before the Directorate General for Competition of the European Commission. At the hearing, both companies were able to crystallize the compelling nature of our merger, which will bring significant benefits to customers, regulators and intermediaries. Furthermore, given the strong prospects for growth for investors as a result of our proposed merger and the company’s current valuation, we recently announced a plan to acquire up to $100 million in stock in the fourth quarter, as part of our Board authorized stock buy-back program.”

The table below summarizes the financial results1 for the third quarter of 2011:

 

1


      3Q11     2Q11     3Q10     D 3Q11
vs. 3Q10
    Year-to-Date     D YTD 11
vs. YTD 10
 

($ in millions, except EPS)

           2011     2010    

Total Revenues2

   $ 1,258      $ 1,092      $ 1,050        20   $ 3,498      $ 3,380        3
  

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

Total Revenues, Less Transaction-Based Expenses3

     704        661        599        18     2,044        1,898        8

Other Operating Expenses4

     416        419        419        (1 %)      1,251        1,253        (0 %) 
  

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

Operating Income4

   $ 288      $ 242      $ 180        60   $ 793      $ 645        23

Net Income4

   $ 186      $ 160      $ 121        54   $ 522      $ 428        22

Diluted Earnings Per Share4

   $ 0.71      $ 0.61      $ 0.46        54   $ 1.98      $ 1.64        21
  

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

Operating Margin

     41     37     30     11  ppts      39     34     5 ppts 

Adjusted EBITDA Margin

     51     47     42     9 ppts      49     45     4  ppts 

 

1 

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.

2 

Includes activity assessment fees.

3 

Transaction-based expenses include Section 31 fees, liquidity payments and routing & clearing fees.

4 

Excludes merger expenses, exit costs, disposal activities and discrete tax items.

“Continued cost discipline during the quarter well-positioned the company to capture the full benefit of higher trading volumes across all venues, with our operating margin increasing to 41% and our incremental margin exceeding 100%, reflecting the strong operating leverage in our model,” Michael S. Geltzeiler, Group Executive Vice President and CFO, NYSE Euronext, commented. “On a constant dollar, constant portfolio basis, our expenses year-to-date are running $53 million, or 4% below the prior year period and we are confident that we will achieve our previously announced full-year 2011 expense guidance of less than $1.650 billion on the same basis.

“Additionally, with over $1 billion in adjusted EBITDA generated in the first 9 months of the year and debt-to-EBITDA level of 1.6 times, our balance sheet continues to strengthen as we prepare for our merger with Deutsche Boerse. As a result of our strong performance and our continuing focus on creating value for our shareholders, we are buying back up to $100 million in stock, on top of the attractive stream of dividends that we expect to pay out to investors in conjunction with our merger.”

THIRD QUARTER 2011 CONSOLIDATED RESULTS

Total revenues, less transaction-based expenses, which include Section 31 fees, liquidity payments and routing and clearing fees (net revenue), was $704 million in the third quarter of 2011, up $105 million, or 18% compared to the third quarter of 2010 and included a $23 million positive impact from currency fluctuations. The $105 million increase in net revenue compared to the third quarter of 2010 was driven by a $75 million, or 27% increase in trading revenue on strong average daily trading volumes (“ADV”) across all trading venues and a $30 million, or 9% increase in non-trading related revenue.

Other operating expenses, excluding merger expenses and exit costs, were $416 million in the third quarter of 2011, down $3 million, or 1% compared to the third quarter of 2010. Excluding the impact of acquisitions, new initiatives and a $10 million negative impact attributable to foreign currency fluctuations, fixed operating expenses were down $21 million, or 5%, compared to the third quarter of 2010.

Based on results through the third quarter of 2011, excluding merger expenses and exit costs, the Company expects to achieve its guidance for full-year 2011 operating expenses of less than $1,650 million on a constant dollar, constant portfolio basis. For the full-year 2011, we anticipate incremental costs from portfolio changes of approximately $28 million (Corporate Board Member, NYSE Blue and Metabit), as well as incremental costs from currency fluctuations of approximately $30 million assuming currency rates remain at year-to-date 2011 averages. Factoring in these portfolio changes and the impact of currency fluctuations, full-year 2011 expenses are expected to be approximately $1,680 million.

Operating income, excluding merger expenses and exit costs, was $288 million, up $108 million, or 60% compared to the third quarter of 2010 and included a $13 million positive impact attributable to foreign currency fluctuations.

Adjusted EBITDA, excluding merger expenses and exit costs, was $360 million, up $111 million, or 45% compared to the third quarter of 2010. Adjusted EBITDA margin was 51% in the third quarter of 2011, compared to 42% in the third quarter of 2010. Year-to-date, the Company has generated over $1.0 billion in adjusted EBITDA, $159 million, or 19% more than the prior year period.

 

2


Non-operating income for the third quarter of 2011 and 2010 includes the impact of New York Portfolio Clearing (loss from associates) and NYSE Liffe U.S. (net loss attributable to non-controlling interest). Beginning in the third quarter of 2011, profits generated by NYSE Amex Options are now being shared with our partners (net income attributable to non-controlling interest). The profit attributable to the non-controlling interest related to NYSE Amex Options was $11 million in the third quarter of 2011, based on the sale of a 52.8% stake in the business. During the third quarter of 2011, approximately 10% of the ownership stake held by NYSE Amex Options partners was put-back to NYSE Euronext, reducing the equity stake held by partners to 47.5%.

The effective tax rate for the full-year 2011 was lowered in the third quarter of 2011 from 26.0% to 25.75%, partially as a result of the NYSE Amex Options semi-mutualization, resulting in an effective tax rate (excluding merger expenses, exit costs and discrete tax items) of 25.0% for the third quarter of 2011. The 24.2% effective tax rate in the third quarter of 2010 included the impact of advance tax rulings following the adoption of favorable tax laws in the Netherlands, which lowered the estimated full-year effective tax rate in 2010 from 27.5% to 26.5%.

The weighted average diluted shares outstanding in the third quarter of 2011 was 263 million shares, up from 262 million shares in the third quarter of 2010.

At September 30, 2011, total debt of $2.1 billion was $0.3 billion below December 31, 2010 levels driven primarily by lower commercial paper outstanding. Cash, cash equivalents and short term financial investments (including $37 million related to Section 31 fees collected from market participants and due to the SEC) were $0.4 billion and net debt was $1.7 billion at the end of the third quarter 2011.

The ratio of debt-to-EBITDA in the third quarter of 2011 declined to 1.6 times, the lowest level since the establishment of NYSE Euronext in April 2007.

Total capital expenditures in the third quarter of 2011 were $49 million, compared to $82 million in the third quarter of 2010. Through the first three quarters of 2011, capital expenditures were $116 million compared to $244 million in 2010 and are now expected to be well below the full-year 2011 guidance of less than $200 million.

Headcount as of September 30, 2011, which includes incremental hires for our growing technology services business and 36 new employees from the Metabit acquisition, was 3,074 up 3% from June 30, 2011 and up 2% from September 30, 2010 levels.

The Board of Directors declared a cash dividend of $0.30 per share for the third quarter of 2011. The third quarter 2011 dividend is payable on December 30, 2011 to shareholders of record as of the close of business on December 15, 2011. The anticipated ex-date will be December 13, 2011.

THIRD QUARTER 2011 SEGMENT RESULTS

Below is a summary of business segment results:

 

     Derivatives      Cash Trading & Listings      Info. Svcs. & Tech. Solutions  

($ in millions)

   Net
Revenue1
     Operating
Income2
     Adjusted
EBITDA2
     Net
Revenue1
     Operating
Income2
     Adjusted
EBITDA2
     Net
Revenue1
     Operating
Income2
     Adjusted
EBITDA2
 

3Q11

   $ 226       $ 129       $ 140       $ 353       $ 155       $ 202       $ 125       $ 31       $ 45   

2Q11

   $ 213       $ 112       $ 126       $ 327       $ 128       $ 174       $ 122       $ 36       $ 46   

3Q10

   $ 188       $ 93       $ 108       $ 298       $ 101       $ 145       $ 113       $ 24       $ 34   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

YTD 2011

   $ 675       $ 387       $ 427       $ 1,008       $ 408       $ 547       $ 363       $ 95       $ 128   

YTD 2010

   $ 638       $ 363       $ 406       $ 931       $ 333       $ 465       $ 330       $ 61       $ 87   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

1 

Net revenue defined as total revenues less transaction-based expenses including Section 31 fees, liquidity payments and routing & clearing fees.

2 

Excludes merger expenses and exit costs.

DERIVATIVES

 

3


Derivatives net revenue of $226 million in the third quarter of 2011 increased $38 million, or 20% compared to the third quarter of 2010 and included an $8 million positive impact from currency fluctuations. The $38 million increase in derivatives net revenue compared to the third quarter of 2010, was driven by higher trading volumes across both European and U.S. derivatives trading venues.

 

 

Global derivatives ADV in the third quarter of 2011 was 9.3 million contracts, an increase of 33% compared to the third quarter of 2010.

 

 

NYSE Euronext European derivatives products ADV in the third quarter of 2011 of 4.4 million contracts increased 14% compared to the third quarter of 2010, but decreased 18% from second quarter of 2011 levels, which benefited from seasonally strong individual equity futures through Bclear, NYSE Liffe’s trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV in the third quarter of 2011 increased 11% compared to the second quarter of 2011. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe.

 

 

U.S. equity options ADV in the third quarter of 2011 increased 53% to 4.9 million contracts compared to the third quarter of 2010 and increased 20% from the second quarter of 2011. NYSE Euronext’s U.S. equity options exchanges accounted for 26% of total consolidated U.S. equity options trading in the third quarter of 2011, in-line with the third quarter of 2010 and the second quarter of 2011.

 

 

NYSE Liffe U.S. continues to experience increased client participation and diversification across both interest rate and MSCI equity index product areas. Since the launch of interest rate products in March of 2011, approximately 11 million interest rate contracts have been traded. In the third quarter of 2011, open interest of 670,000 contracts in Eurodollars represented approximately 7% market share and open interest in U.S. treasury futures has increased to over 53,000 contracts, double the levels registered at the end of the second quarter of 2011.

 

 

After the successful migration to NYSE Liffe U.S. of the flagship MSCI Emerging Markets and MSCI EAFE indices in June of 2011, approximately 750,000 MSCI-based futures contracts traded over the exchange in the third quarter of 2011. Open interest as of September 30, 2011 was over 100,000 contracts, up approximately 50% since the consolidation of open interest on NYSE Liffe U.S.

CASH TRADING AND LISTINGS

Cash Trading and Listings net revenue of $353 million in the third quarter of 2011 increased $55 million, or 18% compared to the third quarter of 2010 and included an $11 million positive impact from currency fluctuations. The $55 million increase in net revenue compared to the third quarter of 2010, was primarily driven by higher trading volumes across both European and U.S. cash equities trading venues.

 

 

European cash ADV of 1.9 million transactions in the third quarter of 2011 increased 40% from 1.4 million transactions in the third quarter of 2010. European cash market share (value traded) in NYSE Euronext’s four core markets was 66% in the third quarter of 2011, down from 73% in the third quarter of 2010 and down from 71% in the second quarter of 2011. The decline in European cash market share in the third quarter of 2011 was driven by higher levels of participation by global trading firms trading on alternative European trading venues.

 

 

In the U.S., cash trading ADV increased 9% to 2.6 billion shares traded from 2.4 billion in the third quarter of 2010. Tape A matched market share was 36% in the third quarter of 2011, down from 38% in the third quarter of 2010, but up from 35% in the second quarter of 2011 levels.

 

 

NYSE Euronext led the global market for listing initial public offerings (IPOs) through the third quarter of 2011 with $28.7 billion in total capital raised from 84 IPOs on its European and U.S. markets, more than any exchange group in the world. During the most recent quarter, the New York Stock Exchange (NYSE) led the U.S. IPO market, with 11 IPOs raising $3.2 billion, or 65% of total proceeds raised from IPOs in the U.S.

 

4


 

NYSE has steadily captured share in technology-based IPOs. NYSE has listed 17 out of 35, or 49% of the tech IPOs year-to-date, up from 44% in 2010. LinkedIn, Active Network, Fusion-io and Pandora’s offerings came amid a recent fervor for high-profile tech IPOs.

 

 

The NYSE has welcomed 9 transfers with total market capitalization of $15.0 billion thus far in 2011, and lost none. SuccessFactors Inc. transferred to the NYSE and cross-listed on the European markets of NYSE Euronext. In addition, Level 3 Communications Inc. transferred to the NYSE on October 20, 2011. This follows the recent trend for transfers, with 44 companies having transferred to the NYSE since 2007.

INFORMATION SERVICES AND TECHNOLOGY SOLUTIONS

Information Services and Technology Solutions revenue was $125 million in the third quarter of 2011, an increase of $12 million, or 11% compared to the third quarter of 2010 and included a $4 million positive impact from currency fluctuations. The $12 million increase in revenue compared to the third quarter of 2010, was primarily driven by higher connectivity revenue related to our data centers in Mahwah and Basildon.

 

 

The Information Services and Technology Solutions segment achieved its highest level of quarterly revenue generation with an operating margin of 25%.

 

 

NYSE Technologies is continuing to work with several tier 1 global banks on potential managed services projects designed to significantly reduce bank technology costs through the outsourcing of their trading infrastructure.

 

 

NYSE Technologies is currently in the process of establishing three new regional liquidity hubs in Latin America, Toronto and Tokyo for clients to access our markets through the Secured Financial Transaction Infrastructure (SFTI) network.

 

 

The acquisition of Metabit, a leading Tokyo based provider of high-performance market access products throughout Japan and Asia, was closed and the business fully-integrated with NYSE Technologies in the third quarter of 2011. Metabit will help NYSE Technologies accelerate growth in Asia.

 

 

The MTF business continues to generate demand for platform hosting, liquidity solutions and market data.

# # #

The accompanying tables include information integral to assessing the Company’s financial performance.

Analyst/Investor/Media Call: November 3, 2011 at 8:00 a.m. (NY/EDT)/1:00 p.m. (Paris/CET)

A presentation and live audio webcast of the third quarter 2011 earnings conference call will be available on the Investor Relations section of NYSE Euronext’s website, http://www.nyseeuronext.com/ir. Those wishing to listen to the live conference via telephone should dial-in at least ten minutes before the call begins. An audio replay of the conference call will be available approximately one hour after the call on the Investor Relations section of NYSE Euronext’s website, http://www.nyseeuronext.com/ir or by dial-in beginning approximately two hours following the conclusion of the live call.

Live Dial-in Information:

United States: 800.599.9829

International: 617.847.8703

Passcode: 69094463

Replay Dial-in Information:

United States: 888.286.8010

International: 617.801.6888

Passcode: 38890823

 

5


Non-GAAP Financial Measures

To supplement NYSE Euronext’s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure, calculated and presented in accordance with GAAP. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results, but are provided to (i) present the effects of certain merger expenses, exit costs, disposal activities and discrete tax items, and (ii) improve overall understanding of NYSE Euronext’s current financial performance and its prospects for the future. Specifically, NYSE Euronext believes the non-GAAP financial results provide useful information to both management and investors regarding certain additional financial and business trends relating to financial condition and operating results. In addition, management uses these measures for reviewing financial results and evaluating financial performance. The non-GAAP adjustments for all periods presented are based upon information and assumptions available as of the date of this release.

LOGO NYSE Euronext Earnings News Release with Tables and Operating Data

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company’s exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext’s equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world’s second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (“SEC”) that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation,

 

6


facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

Forward-Looking Statements

This document includes forward-looking statements about NYSE Euronext, Deutsche Boerse AG, Holding, the enlarged group and other persons, which may include statements about the proposed business combination, the likelihood that such transaction could be consummated, the effects of any transaction on the businesses of NYSE Euronext or Deutsche Boerse AG, and other statements that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and actual results of operations, financial condition and liquidity, and the development of the industries in which NYSE Euronext and Deutsche Boerse AG operate may differ materially from those made in or suggested by the forward-looking statements contained in this document. Any forward-looking statements speak only as at the date of this document. Except as required by applicable law, none of NYSE Euronext, Deutsche Boerse AG or Holding undertakes any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Media

+31.20.550.4488 (Amsterdam)

+32.2.509.1392 (Brussels)

+351.217.900.029 (Lisbon)

+44.20.7379.2789 (London)

+1.212.656.2140 (New York)

+33.1.49.27.11.33 (Paris)

CONTACT: Investor Relations

+1.212.656.5700 (New York)

 

7


NYSE Euronext

Condensed consolidated statements of income (unaudited)

(in millions, except per share data)

 

     Three months ended     Nine months ended September 30,  
     Sept. 30, 2011     June 30, 2011     Sept. 30, 2010     2011     2010  

Revenues

          

Transaction and clearing fees

   $ 904      $ 742      $ 726      $ 2,461      $ 2,415   

Market data

     93        92        94        281        278   

Listing

     113        112        105        334        315   

Technology services

     92        89        82        263        236   

Other revenues

     56        57        43        159        136   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     1,258        1,092        1,050        3,498        3,380   

Transaction-based expenses:

          

Section 31 fees

     109        89        77        287        239   

Liquidity payments, routing and clearing

     445        342        374        1,167        1,243   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues, less transaction-based expenses

     704        661        599        2,044        1,898   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other operating expenses

          

Compensation

     160        158        147        480        479   

Depreciation and amortization

     72        70        69        212        201   

Systems and communications

     46        45        52        143        151   

Professional services

     77        73        76        219        200   

Selling, general and administrative

     61        73        75        197        222   

Merger expenses and exit costs

     29        18        25        68        70   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total other operating expenses

     445        437        444        1,319        1,323   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     259        224        155        725        575   

Net interest and investment income (loss)

     (29     (30     (26     (88     (78

Loss from associates

     (2     (2     (1     (5     (4

Other (loss) income

     (1     1        —          —          53   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     227        193        128        632        546   

Income tax provision

     (21     (43     (5     (126     (119
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     206        150        123        506        427   

Net (income) loss attributable to noncontrolling interest

     (6     4        5        2        15   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to NYSE Euronext

   $ 200      $ 154      $ 128      $ 508      $ 442   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share attributable to NYSE Euronext

   $ 0.76      $ 0.59      $ 0.49      $ 1.94      $ 1.69   

Diluted earnings per share attributable to NYSE Euronext

   $ 0.76      $ 0.59      $ 0.49      $ 1.93      $ 1.69   

Basic weighted average shares outstanding

     262        262        261        262        261   

Diluted weighted average shares outstanding

     263        263        262        263        262   

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

     Three months ended     Nine months ended September 30,  

Non-GAAP Reconciliation

   Sept. 30, 2011     June 30, 2011     Sept. 30, 2010     2011     2010  

Income before income taxes - GAAP

   $ 227      $ 193      $ 128      $ 632      $ 546   

Excluding:

          

Net gain on disposal activities

     —          —          —          —          (54

Merger expenses and exit costs

     29        18        25        68        70   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes - as adjusted

     256        211        153        700        562   

Income tax provision

     (64     (55     (37     (180     (149
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income - as adjusted

     192        156        116        520        413   

Net (income) loss attributable to noncontrolling interest

     (6     4        5        2        15   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to NYSE Euronext - as adjusted

   $ 186      $ 160      $ 121      $ 522      $ 428   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share attributable to NYSE Euronext - as adjusted

   $ 0.71      $ 0.61      $ 0.46      $ 1.98      $ 1.64   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

8


NYSE Euronext

Segment Results (unaudited)

(in millions)

 

        Three months ended     Three months ended  
        September 30, 2011     September 30, 2010  
        Derivatives     Cash Trading
and Listings
    Information
Services and
Technology
Solutions
    Corporate
and
Eliminations
    Consolidated     Derivatives     Cash
Trading and
Listings
    Information
Services and
Technology
Solutions
    Corporate and
Eliminations
    Consolidated  

Revenues

                     

Transaction and clearing fees

    $ 288      $ 616      $ —        $ —        $ 904      $ 223      $ 503      $ —        $ —        $ 726   

Market data

      11        49        33        —          93        11        52        31        —          94   

Listing

      —          113        —          —          113        —          105        —          —          105   

Technology services

      —          —          92        —          92        —          —          82        —          82   

Other revenues

      9        47        —          —          56        9        34        —          —          43   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

      308        825        125        —          1,258        243        694        113        —          1,050   

Transaction-based expenses:

                     

Section 31 fees

      —          109        —          —          109        —          77        —          —          77   

Liquidity payments, routing and clearing

      82        363        —          —          445        55        319        —          —          374   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues, less transaction-based expenses

      226        353        125        —          704        188        298        113        —          599   

Depreciation and amortization

  [a]     11        47        14        —          72        15        44        10        —          69   

Merger expenses and exit costs (M&E)

  [b]     1        6        2        20        29        5        15        5        —          25   

Other operating expenses

      86        151        80        27        344        80        153        79        38        350   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income - GAAP

  [c]   $ 128      $ 149      $ 29      $ (47   $ 259      $ 88      $ 86      $ 19      $ (38   $ 155   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income excluding M&E

  [c] + [b]   $ 129      $ 155      $ 31      $ (27   $ 288      $ 93      $ 101      $ 24      $ (38   $ 180   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

  [c] + [a] + [b]   $ 140      $ 202      $ 45      $ (27   $ 360      $ 108      $ 145      $ 34      $ (38   $ 249   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating margin excluding M&E

      57     44     25     N/M        41     49     34     21     N/M        30

Adjusted EBITDA margin

      62     57     36     N/M        51     57     49     30     N/M        42
        Nine months ended     Nine months ended  
        September 30, 2011     September 30, 2010  
        Derivatives     Cash Trading
and Listings
    Information
Services and
Technology
Solutions
    Corporate
and
Eliminations
    Consolidated     Derivatives     Cash
Trading and
Listings
    Information
Services and
Technology
Solutions
    Corporate and
Eliminations
    Consolidated  

Revenues

                     

Transaction and clearing fees

    $ 825      $ 1,636      $ —        $ —        $ 2,461      $ 783      $ 1,632      $ —        $ —        $ 2,415   

Market data

      35        147        99        —          281        35        149        94        —          278   

Listing

      —          334        —          —          334        —          315        —          —          315   

Technology services

      —          —          264        (1     263        —          —          236        —          236   

Other revenues

      31        129        —          (1     159        28        109        —          (1     136   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

      891        2,246        363        (2     3,498        846        2,205        330        (1     3,380   

Transaction-based expenses:

                     

Section 31 fees

      —          287        —          —          287        —          239        —          —          239   

Liquidity payments, routing and clearing

      216        951        —          —          1,167        208        1,035        —          —          1,243   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues, less transaction-based expenses

      675        1,008        363        (2     2,044        638        931        330        (1     1,898   

Depreciation and amortization

  [a]     40        139        33        —          212        43        132        26        —          201   

Merger expenses and exit costs (M&E)

  [b]     3        11        4        50        68        13        41        15        1        70   

Other operating expenses

      248        461        235        95        1,039        232        466        243        111        1,052   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income - GAAP

  [c]   $ 384      $ 397      $ 91      $ (147   $ 725      $ 350      $ 292      $ 46      $ (113   $ 575   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income excluding M&E

  [c] + [b]   $ 387      $ 408      $ 95      $ (97   $ 793      $ 363      $ 333      $ 61      $ (112   $ 645   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

  [c] + [a] + [b]   $ 427      $ 547      $ 128      $ (97   $ 1,005      $ 406      $ 465      $ 87      $ (112   $ 846   
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating margin excluding M&E

      57     40     26     N/M        39     57     36     18     N/M        34

Adjusted EBITDA margin

      63     54     35     N/M        49     64     50     26     N/M        45

N/M = Not meaningful

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

9


NYSE Euronext

Fixed operating expenses (unaudited)

(in millions)

 

Fixed operating expenses for the three months ended September 30, 2011 - GAAP

   $ 445       

Less:

      

Merger expenses and exit costs

     (29    
  

 

 

     
   $ 416       

Excluding the impact of:

      

Currency translation

     (10    

Acquisitions and new business initiatives

     (8   *  
  

 

 

     

Fixed operating expenses for the three months ended September 30, 2011 - as adjusted

   $ 398        [a]
  

 

 

     

Fixed operating expenses for the three months ended September 30, 2010 - GAAP

   $ 444       

Less:

      

Merger expenses and exit costs

     (25    
  

 

 

     
   $ 419        [b]
  

 

 

     

Variance ($)

   $ (21     [a] - [b] = [c]
  

 

 

     

Variance (%)

     -5     [c] / [b]

Fixed operating expenses for the nine months ended September 30, 2011 - GAAP

   $ 1,319       

Less:

      

Merger expenses and exit costs

     (68    
  

 

 

     
   $ 1,251       

Excluding the impact of:

      

Currency translation

     (28    

Acquisitions and new business initiatives

     (23   *  
  

 

 

     

Fixed operating expenses for the nine months ended September 30, 2011 - as adjusted

   $ 1,200        [a]
  

 

 

     

Fixed operating expenses for the nine months ended September 30, 2010 - GAAP

   $ 1,323       

Less:

      

Merger expenses and exit costs

     (70    
  

 

 

     
   $ 1,253        [b]
  

 

 

     

Variance ($)

   $ (53     [a] - [b] = [c]
  

 

 

     

Variance (%)

     -4     [c] / [b]

 

* Includes the contribution of APX, Corporate Board Member and new business initiatives.

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

10


NYSE Euronext

Condensed consolidated statements of financial condition (unaudited)

(in millions)

 

     September 30,
2011
     December 31,
2010
 

Assets

     

Current assets:

     

Cash, cash equivalents and short term financial investments

   $ 370       $ 379   

Accounts receivable, net

     489         526   

Deferred income taxes

     70         120   

Other current assets

     194         149   
  

 

 

    

 

 

 

Total current assets

     1,123         1,174   

Property and equipment, net

     974         1,021   

Goodwill

     4,091         4,050   

Other intangible assets, net

     5,839         5,837   

Deferred income taxes

     564         633   

Other assets

     635         663   
  

 

 

    

 

 

 

Total assets

   $ 13,226       $ 13,378   
  

 

 

    

 

 

 

Liabilities and equity

     

Accounts payable and accrued expenses

   $ 780       $ 910   

Deferred revenue

     244         176   

Short term debt

     31         366   

Deferred income taxes

     24         2   
  

 

 

    

 

 

 

Total current liabilities

     1,079         1,454   

Long term debt

     2,084         2,074   

Deferred income taxes

     1,941         2,007   

Accrued employee benefits

     440         499   

Deferred revenue

     376         366   

Other liabilities

     63         134   
  

 

 

    

 

 

 

Total liabilities

     5,983         6,534   
  

 

 

    

 

 

 

Redeemable noncontrolling interest

     256         —     
  

 

 

    

 

 

 

Equity

     6,987         6,844   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 13,226       $ 13,378   
  

 

 

    

 

 

 

 

11


NYSE Euronext

Selected Statistical Data:

Volume Summary

 

    Average Daily Volume     Total Volume     Total Volume  
(Unaudited)   3Q11     2Q11     D 3Q11
vs. 2Q11
    3Q10     D 3Q11
vs. 3Q10
    3Q11     2Q11     D 3Q11
vs. 2Q11
    3Q10     D 3Q11
vs. 3Q10
    YTD 2011     YTD 2010     % D  

Number of Trading Days - European Markets

    66        63          66          66        63          66          193        192     

Number of Trading Days - U.S. Markets

    64        63          64          64        63          64          189        188     

European Derivatives Products (contracts in thousands)

    4,349        5,294        -17.9     3,828        13.6     287,064        333,522        -13.9     252,695        13.6     917,114        975,899        -6.0

of which Bclear

    826        2,125        -61.1     845        -2.2     54,508        133,874        -59.3     55,746        -2.2     237,718        284,009        -16.3

Avg. Net Rate Per Contract (ex. Bclear)

  $ 0.679      $ 0.741        -8.4   $ 0.670        1.3   $ 0.679      $ 0.741        -8.4   $ 0.670        1.3   $ 0.702      $ 0.658        6.4

Avg. Net Rate Per Contract (ex. Bclear) - Currency Neutral

  $ 0.679      $ 0.732        -7.2   $ 0.696        -2.4   $ 0.679      $ 0.732        -7.2   $ 0.696        -2.4      

Total Interest Rate Products1

    2,347        2,147        9.4     1,952        20.3     154,927        135,231        14.6     128,787        20.3     462,950        467,703        -1.0

Short Term Interest Rate Products

    2,198        2,006        9.6     1,842        19.3     145,086        126,347        14.8     121,540        19.4     435,804        445,381        -2.2

Medium and Long Term Interest Rate Products

    149        141        5.7     110        35.6     9,841        8,884        10.8     7,247        35.8     27,146        22,322        21.6

Total Equity Products2

    1,923        3,063        -37.2     1,795        7.2     126,943        192,980        -34.2     118,533        7.1     438,033        496,067        -11.7 %

Individual Equity Products

    1,250        2,535        -50.7     1,246        0.3     82,515        159,703        -48.3     82,269        0.3     323,229        376,046        -14.0

Futures

    658        1,984        -66.8     696        -5.5     43,421        124,971        -65.3     45,965        -5.5     205,169        242,981        -15.6

Options

    592        551        7.4     550        7.7     39,094        34,731        12.6     36,305        7.7     118,060        133,065        -11.3

Equity Index Products

    673        528        27.4     549        22.6     44,428        33,277        33.5     36,264        22.5     114,805        120,021        -4.3

of which Bclear

    826        2,125        -61.1     845        -2.2     54,508        133,874        -59.3     55,746        -2.2     237,718        284,009        -16.3

Individual Equity Products

    733        2,053        -64.3     768        -4.5     48,400        129,324        -62.6     50,697        -4.5     221,876        265,069        -16.3

Futures

    635        1,959        -67.6     685        -7.3     41,901        123,429        -66.1     45,223        -7.3     201,767        242,099        -16.7

Options

    98        94        5.2     83        18.7     6,499        5,895        10.2     5,475        18.7     20,109        22,969        -12.5

Equity Index Products

    93        72        28.1     76        21.0     6,108        4,551        34.2     5,048        21.0     15,841        18,940        -16.4

Commodity Products

    79        84        -6.3     81        -2.5     5,193        5,312        -2.2     5,375        -3.4     16,131        12,128        33.0

U.S. Derivatives Products (contracts in thousands)

                         

Avg. Net Rate Per Contract (ex. Liffe U.S. volumes)

  $ 0.154      $ 0.165        -6.7   $ 0.171        -9.9   $ 0.154      $ 0.165        -6.7   $ 0.171        -9.9   $ 0.161      $ 0.172        -6.4

Equity Options Contracts3

    4,866        4,052        20.1     3,189        52.6     311,430        255,306        22.0     204,078        52.6     840,169        687,388        22.2

Total Consolidated Options Contracts

    18,477        15,759        17.3     12,484        48.0     1,182,554        992,810        19.1     798,990        48.0     3,248,325        2,642,003        22.9

Share of Total Consolidated Options Contracts

    26.3     25.7       25.5       26.3     25.7       25.5       25.9     26.0  

NYSE Liffe U.S.

                         

Futures and Futures Options Volume*

    117.8        93.4        26.1     10.7        1001.0     7,775.5        5,980.7        30.0     684.8        1035.4     15,100.6        3,122.6        383.6

European Cash Products (trades in thousands)

    1,907        1,540        23.9     1,364        39.8     125,891        96,999        29.8     90,023        39.8     338,267        284,732        18.8

Avg. Net Revenue Per Transaction

  $ 0.635      $ 0.742        -14.4   $ 0.655        -3.1   $ 0.635      $ 0.742        -14.4   $ 0.655        -3.1   $ 0.677      $ 0.699        -3.1

Avg. Net Revenue Per Transaction - Currency Neutral

  $ 0.635      $ 0.727        -12.7   $ 0.716        -11.3   $ 0.635      $ 0.727        -12.7   $ 0.716        -11.3      

Equities

    1,832        1,482        23.6     1,310        39.8     120,893        93,350        29.5     86,444        39.9     325,084        273,348        18.9

Exchange-Traded Funds

    25        16        51.8     16        55.4     1,641        1,032        59.0     1,059        54.9     3,988        3,432        16.2

Structured Products

    46        36        26.8     33        40.1     3,052        2,298        32.9     2,197        38.9     8,223        6,844        20.1

Bonds

    5        5        -8.9     5        -7.6     305        319        -4.5     323        -5.6     972        1,108        -12.3

U.S. Cash Products (shares in millions)

    2,608        2,075        25.7     2,396        8.8     166,914        130,722        27.7     153,359        8.8     440,850        511,225        -13.8

Avg. Net Fee Per 100 Shares Handled

  $ 0.0383      $ 0.0390        -1.8   $ 0.0320        19.7   $ 0.0383      $ 0.0390        -1.8   $ 0.0320        19.7   $ 0.0381      $ 0.0311        22.5

NYSE Listed (Tape A) Issues 4

                         

Handled Volume 5

    1,806        1,461        23.6     1,720        5.0     115,591        92,072        25.5     110,058        5.0     311,061        370,774        -16.1

Matched Volume 6

    1,717        1,384        24.0     1,625        5.7     109,900        87,216        26.0     104,021        5.7     294,921        347,375        -15.1

Total NYSE Listed Consolidated Volume

    4,801        3,935        22.0     4,275        12.3     307,295        247,909        24.0     273,580        12.3     838,416        949,963        -11.7

Share of Total Consolidated Volume

                         

Handled Volume 5

    37.6     37.1       40.2       37.6     37.1       40.2       37.1     39.0  

Matched Volume 6

    35.8     35.2       38.0       35.8     35.2       38.0       35.2     36.6  

NYSE Arca & Amex (Tape B) Listed Issues

                         

Handled Volume 5

    469        335        40.1     352        33.2     30,007        21,085        42.3     22,524        33.2     72,582        76,244        -4.8

Matched Volume 6

    423        301        40.5     320        32.2     27,094        18,976        42.8     20,499        32.2     65,340        68,405        -4.5

Total NYSE Arca & Amex Listed Consolidated Volume

    1,798        1,287        39.7     1,292        39.2     115,086        81,111        41.9     82,696        39.2     279,949        288,405        -2.9

Share of Total NYSE Arca & NYSE Amex Listed Consolidated Volume

                         

Handled Volume 5

    26.1     26.0       27.2       26.1     26.0       27.2       25.9     26.4  

Matched Volume 6

    23.5     23.4       24.8       23.5     23.4       24.8       23.3     23.7  

Nasdaq Listed Issues (Tape C)

                         

Handled Volume 5

    333        279        19.2     325        2.6     21,316        17,597        21.1     20,777        2.6     57,208        64,206        -10.9

Matched Volume 6

    292        237        23.5     280        4.4     18,719        14,924        25.4     17,933        4.4     49,214        54,021        -8.9

Total Nasdaq Listed Consolidated Volume

    2,183        1,996        9.3     2,020        8.0     139,681        125,745        11.1     129,308        8.0     392,592        431,299        -9.0

Share of Total Nasdaq Listed Consolidated Volume

                         

Handled Volume 5

    15.3     14.0       16.1       15.3     14.0       16.1       14.6     14.9  

Matched Volume 6

    13.4     11.9       13.9       13.4     11.9       13.9       12.5     12.5  

Exchange-Traded Funds 5,7

                         

Handled Volume 5

    455        309        47.4     344        32.2     29,119        19,446        49.7     22,034        32.2     68,122        73,607        -7.5

Matched Volume 6

    410        277        48.0     313        31.1     26,271        17,468        50.4     20,037        31.1     61,281        66,172        -7.4

Total ETF Consolidated Volume

    1,783        1,210        47.3     1,287        38.5     114,109        76,252        49.6     82,366        38.5     267,573        285,403        -6.2

Share of Total ETF Consolidated Volume

                         

Handled Volume 5

    25.5     25.5       26.8       25.5     25.5       26.8       25.5     25.8  

Matched Volume 6

    23.0     22.9       24.3       23.0     22.9       24.3       22.9     23.2  

 

1 

Data includes currency products.

2

Includes trading activities for Bclear, NYSE Liffe’s service for Equity OTC derivatives.

 

3 

Includes trading in U.S. equity options contracts, not equity-index options.

4 

Includes all volume executed in NYSE Group crossing sessions.

5 

Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group’s exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

6 

Represents the total number of shares of equity securities and ETFs executed on the NYSE Group’s exchanges.

7 

Data included in previously identified categories.

* 

Includes trading from Interest rate futures over NYSE Liffe U.S. for 9 trading days in 1Q11. ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

 

12


NYSE Euronext

Selected Statistical Data:

Other Operating Statistics

 

     Three Months Ended  
(Unaudited)    Sept. 30, 2011     June 30, 2011     Sept. 30, 2010  

NYSE Euronext Listed Issuers

      

NYSE Listed Issuers

      

Issuers listed on U.S. Markets1

     2,948        2,956        2,928   

Number of new issuer listings1

     78        155        31   

Capital raised in connection with new listings ($millions)2

   $ 2,199      $ 11,709      $ 3,650   

Euronext Listed Issuers

      

Issuers listed on Euronext1

     947        964        995   

Number of new issuer listings3

     17        20        21   

Capital raised in connection with new listings ($millions)2

   $ 107      $ 72      $ 58   

NYSE Euronext Market Data

      

NYSE Market Data4

      

Share of Tape A revenues (%)

     44.5     45.8     50.3

Share of Tape B revenues (%)

     30.0     30.2     33.1

Share of Tape C revenues (%)

     18.7     18.4     21.8

Professional subscribers (Tape A)

     374,784        383,606        381,658   

Euronext Market Data

      

Number of terminals

     231,474        231,544        239,098   

NYSE Euronext Operating Expenses

      

NYSE Euronext employee headcount

      

NYSE Euronext headcount

     3,074        2,988        3,030   

NYSE Euronext Financial Statistics

      

NYSE Euronext foreign exchange rate

      

Average €/US$ exchange rate

   $ 1.414      $ 1.439      $ 1.292   

Average £/US$ exchange rate

   $ 1.611      $ 1.631      $ 1.550   

 

1 

Figures for NYSE listed issuers include listed operating companies, special-purpose acquisition companies and closed-end funds listed on the NYSE and NYSE Amex and do not include NYSE Arca or structured products listed on the NYSE. There were 1,328 ETFs and 2 operating companies exclusively listed on NYSE Arca as of September 30, 2011. There were 457 corporate structured products listed on the NYSE as of September 30, 2011. Figures for new issuer listings include NYSE new listings (including new operating companies, special-purpose acquisition companies and closed-end funds listing on NYSE) and new ETP listings on NYSE Arca (NYSE Amex is excluded). Figures for Euronext present the operating companies were listed on Euronext and do not include NYSE Alternext, Free Market, closed-end funds, ETFs and structured product (warrants and certificates). As of September 30, 2011, 181 companies were listed on NYSE Alternext, 265 on Free Market and 678 ETFs were listed on NextTrack.

2 

Euronext figures show capital raised in millions of dollars by operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (warrants and certificates). NYSE figures show capital raised in millions of dollars by operating companies listed on NYSE and NYSE Arca and do not include closed-end funds, ETFs and structured products.

3 

Euronext figures include operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (warrants and certificates).

4 

“Tape A” represents NYSE listed securities, “Tape B” represents NYSE Arca and NYSE Amex listed securities, and “Tape C” represents Nasdaq listed securities. Per Regulation NMS, as of April 1, 2007, share of revenues is derived through a formula based on 25% share of trading, 25% share of value traded, and 50% share of quoting, as reported to the consolidated tape. Prior to April 1, 2007, share of revenues for Tape A and B was derived based on number of trades reported to the consolidated tape, and share of revenue for Tape C was derived based on an average of share of trades and share of volume reported to the consolidated tape. The consolidated tape refers to the collection and dissemination of market data that multiple markets make available on a consolidated basis. Share figures exclude transactions reported to the FINRA/NYSE Trade Reporting Facility.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

 

13